Chinese herbals
This article was originally published in The Tan Sheet
Executive Summary
FDA says its Office of Regulatory Affairs is working with the agency's Los Angeles district office to investigate the presence of the diabetes drugs glyburide and phenformin found in five Chinese herbals sold by Sino American Health Products and Chinese Angel Health Products. The California Department of Health posted a public health warning about the products Feb. 15 (1"The Tan Sheet" Feb. 21, p. 9). Both firms have issued press releases alerting consumers about the items and recall actions have been initiated. FDA also has issued "automatic detention" import alerts 66-10 and 66-41 notifying U.S. Customs and postal service officials about the products
You may also be interested in...
Five Chinese Herbals Contain Drug Ingredients, Calif. Health Dept. Warns
The California Department of Health Services' Food & Drug branch posted a public health warning Feb. 15 notifying consumers that five Chinese herbal products contain the prescription diabetes drugs glyburide and phenformin.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands